Hunan Warrant Pharmaceutical (688799.SH) has received the approval notice for the supplementary application of amlodipine hydrochloride tablets.

Hunan Warrant Pharmaceutical(688799.SH) announced that the company has received a "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration regarding the change in the holder of the market authorization for Benidipine Hydrochloride tablets. Benidipine Hydrochloride tablets are indicated for primary hypertension and angina.